Atinum

Intelligent future-built platform unlocks hidden revenue potential. CENTURY CITY, CA / ACCESS Newswire / March 25, 2025 / Ateliere Creative

We recently compiled a list of the Top 8 Trending AI Stock Updates On Wall Street Today. In this article, we are going to take a look at where Itron Inc. (NASDAQ:ITRI) stands against the other AI stocks.

Anduril and Microsoft partner to advance the IVAS program, delivering next-gen AR/VR and AI capabilities to the US Army, enhancing battlefield awareness and mission command.

The market's appetite for AI applications in healthcare is rapidly increasing, with TEM emerging as a top contender in this high-growth sector.

Another company involved in using AI to repurpose failed drugs - as well as drugs that have already been approved - is BioXcel Therapeutics. Unlike Ignota, however, the company focuses on compounds that have already demonstrated safety in prior clinical trials, but have been discontinued by their developers for various other reasons.

Iktos, a global leader in AI-driven drug discovery, has secured a prestigious €2.5 million grant from the European Innovation Council (EIC) Accelerator to advance its AI and robotics synthesis automation technology.

AI helps scientists decode a cone snail toxin's targets, paving the way for safer drug development and ecological research.

TEM basically mixes genomic and clinical data with AI. This is at the core of their new offerings for precision diagnostics and personalized treatments. Read more here.